Literature DB >> 6765930

Inhibition of peripheral aromatization by aromatase inhibitors, 4-hydroxy- and 4-acetoxy-androstene-3,17-dione.

A M Brodie, C Longcope.   

Abstract

To determine the effect of aromatase inhibitors on peripheral aromatization, male rhesus monkeys were infused with [7-3H]androstenedione and [4-14C]estrone before and during treatment with 4-hdyroxy-androstene-3,17-dione (50 mg/kg each; four monkeys) or 4-acetoxy-androstene-3,17-dione (700 mg each; two monkeys). In all six monkeys, no specific effects on the MCRs of androstenedione and estrone, the interconversion of androgens or estrogens, or androstenedione conversion to dihydrotestosterone were noted. In five of the six animals, aromatization rates were reduced by up to 97% of control values. The results demonstrate that these compounds inhibit peripheral aromatization and, together with our other results, suggest that aromatase inhibitors may be a useful treatment for estrogen-dependent cancer.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6765930     DOI: 10.1210/endo-106-1-19

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

Review 2.  Recent advances in studies on estrogen biosynthesis.

Authors:  A M Brodie
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

Review 3.  Comprehensive pharmacology and clinical efficacy of aromatase inhibitors.

Authors:  V C Njar; A M Brodie
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 4.  Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.

Authors:  V Craig Jordan; Angela M H Brodie
Journal:  Steroids       Date:  2006-12-13       Impact factor: 2.668

Review 5.  Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer.

Authors:  L R Wiseman; D McTavish
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

6.  Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.

Authors:  P G Spinola; B Marchetti; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

Review 7.  Successful Targeted Therapies for Breast Cancer: the Worcester Foundation and Future Opportunities in Women's Health.

Authors:  Balkees Abderrahman; V Craig Jordan
Journal:  Endocrinology       Date:  2018-08-01       Impact factor: 4.736

Review 8.  Aromatase inhibitor development for treatment of breast cancer.

Authors:  S Masamura; H Adlercreutz; H Harvey; A Lipton; L M Demers; R J Santen; S J Santner
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

9.  Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil.

Authors:  Norbert Baume; Nicolas Jan; Caroline Emery; Béatrice Mandanis; Carine Schweizer; Sylvain Giraud; Nicolas Leuenberger; François Marclay; Raul Nicoli; Laurent Perrenoud; Neil Robinson; Jiri Dvorak; Martial Saugy
Journal:  Br J Sports Med       Date:  2015-05       Impact factor: 13.800

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.